Kyle Guse - CFO, Gen Counsel and Secretary at Atossa Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CFO, Gen Counsel and Secretary
Stock Symbol
ATOS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kyle Guse since 12/17/2023

Holdings reported by Kyle Guse for Atossa Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (right to buy) 558K Mar 2, 2023 Direct Common Stock

Transactions reported by Kyle Guse for Atossa Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.